The care for chronic disease management addresses pain points at scale and has the potential to become a large business globally.

Akshay Datt speaks with Jogin Desai, Founder & CEO of Eyestem, a leading cell therapy company in India that aims to set a new benchmark for quality and affordability in this domain.

Dr. Desai has previously served as the CEO of Cenduit and has extensive experience in growing and nurturing businesses. He founded Eyestem in 2016 to develop cell therapy in order to address Age-related Macular Degeneration (AMD), an eye disease that causes vision loss.

Tune in to this episode to hear Dr Desai speak about how Eyestem plans to pioneer the development of the cell therapy industry.

Key Takeaways!

  • Developing the product.
  • Targeting incurable diseases.
  •  Commercializing Eyestem.

The care for chronic disease management addresses pain points at scale and has the potential to become a large business globally.

Akshay Datt speaks with Jogin Desai, Founder & CEO of Eyestem, a leading cell therapy company in India that aims to set a new benchmark for quality and affordability in this domain.

Dr. Desai has previously served as the CEO of Cenduit and has extensive experience in growing and nurturing businesses. He founded Eyestem in 2016 to develop cell therapy in order to address Age-related Macular Degeneration (AMD), an eye disease that causes vision loss.

Tune in to this episode to hear Dr Desai speak about how Eyestem plans to pioneer the development of the cell therapy industry.

Key Takeaways!

  • Developing the product.
  • Targeting incurable diseases.
  •  Commercializing Eyestem.

Facebook
Twitter
LinkedIn
Pocket
Email

FEATURED GUESTS

Jogin Desai Founder and CEO, Eyestem

About The Spotlight

At the Spotlight, we go behind the scenes and identify and highlight the upcoming disruptors from the startup space!

HOSTED BY

No data was found

EXPLORE MORE SHOWS

Kahaniyon Ka Guccha Podcast
podium spotlight show pic
Soulbrews With Sheba Podcast
Marketing Connect Podcast